NCT04230681View on ClinicalTrials.gov

Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
Obstructive Sleep ApneaTonsillitis
Interventions
DRUG

Hydromorphone

Patients will be randomized to one of two opioids for the treatment of post-operative pain.

DRUG

Fentanyl

Fentanyl

Trial Locations (1)

63110

Washington University School of Medicine/Barnes-Jewish Hospital, St Louis

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Washington University School of Medicine

OTHER

NCT04230681 - Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery | Biotech Hunter | Biotech Hunter